| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/10/2010 | CA2753700A1 Anti-rhesus d monoclonal antibody |
| 09/10/2010 | CA2753681A1 Vangl1 peptides and vaccines including the same |
| 09/10/2010 | CA2753621A1 Antibodies and epitopes specific to misfolded prion protein |
| 09/09/2010 | US20100228008 Dyes linked to target molecules, oligonucleotides or polynucleotides comprising dye molecules, composite dyes and other compositions useful for detecting or quantifying desirable target molecules |
| 09/09/2010 | US20100228007 Mhc-peptide complex binding ligands |
| 09/09/2010 | US20100227805 Molecules and Methods of Using Same for Treating CCR5/CCR5 Ligands Associated Diseases |
| 09/09/2010 | US20100227802 Methods and materials relating to PAQR polypeptides and polynucleotides |
| 09/09/2010 | US20100227774 Method For Generating and Selecting Antibodies Against Target Protein |
| 09/09/2010 | US20100227417 Methods and Kits for Detection of Thromboxane A2 Metabolites |
| 09/09/2010 | US20100227394 Fusion antibodies |
| 09/09/2010 | US20100227373 Recombinant Carrier Molecule for Expression, Delivery and Purification of Target Polypeptides |
| 09/09/2010 | US20100227343 Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer |
| 09/09/2010 | US20100227339 Differential immunoassay for prrs vaccine antibody |
| 09/09/2010 | US20100227335 Matrix metalloproteinase-7 (mmp-7) monoclonal antibodies and methods for their use in the detection of ovarian cancer |
| 09/09/2010 | US20100226991 Solid inorganic/organic hybrid with modified surface |
| 09/09/2010 | US20100226974 Antibody recognizing antigen |
| 09/09/2010 | US20100226929 Direct Oxidation of Calcium/Calmodulin Dependent Protein Kinase II and Associated Diagnostic and Therapeutic Methods |
| 09/09/2010 | US20100226928 Lyophilised Antibody Formulation |
| 09/09/2010 | US20100226925 Homogeneous Antibody Populations |
| 09/09/2010 | US20100226923 Antibodies that bind il-4 and/or il-13 and their uses |
| 09/09/2010 | US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides |
| 09/09/2010 | US20100226915 AGER-Peptides and Use Thereof |
| 09/09/2010 | US20100226914 Method for preparation of single chain antibodies |
| 09/09/2010 | US20100226912 RECOMBINANT PROTEIN PRODUCTION IN AVIAN EBx® CELLS |
| 09/09/2010 | US20100226884 Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R) |
| 09/09/2010 | US20100226880 Treatment with anti-vegf antibodies |
| 09/09/2010 | US20100226854 MHC Peptide Complexes and Uses Thereof in Infectious Diseases |
| 09/08/2010 | EP2226636A1 Cancer diagnosis and treatment using anti-robo1 antibody |
| 09/08/2010 | EP2226635A1 Immunodetection assay for mycobacterium tuberculosis complex |
| 09/08/2010 | EP2226382A1 Protease for wound conditioning and skin care |
| 09/08/2010 | EP2226334A2 Immunoregulatory structures from normally occuring proteins |
| 09/08/2010 | EP2225280A1 Bivalent, bispecific antibodies |
| 09/08/2010 | EP2225279A1 Bivalent, bispecific antibodies |
| 09/08/2010 | EP2225278A2 Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors |
| 09/08/2010 | EP2225276A1 Antibodies to tnf alpha |
| 09/08/2010 | EP2225275A1 Protein formulation |
| 09/08/2010 | EP2225274A1 Compositions and methods for early pregnancy diagnosis |
| 09/08/2010 | EP2225273A1 Stability testing of antibodies |
| 09/08/2010 | EP2225268A1 Immunoassays and kits for the detection of ngal |
| 09/08/2010 | EP2225265A2 Streptococcus pneumoniae vaccines |
| 09/08/2010 | EP2225262A2 Peptides specific for hepatocellular carcinoma cells and applications thereof |
| 09/08/2010 | EP2224955A1 14-3-3 antagonists for the prevention and treatment of arthritis |
| 09/08/2010 | EP2224954A2 Antibodies that bind human dendritic and epithelial cell 205 (dec-205) |
| 09/08/2010 | EP1735349B1 Method of assessing the risk of ischemic cardiovascular disease using phosphorylcholine conjugates |
| 09/08/2010 | EP1692183B1 Chimeric anti cd44 antibodies and their use for treating acute myeloid leukemia |
| 09/08/2010 | EP1636254B1 Replikin peptides and uses thereof |
| 09/08/2010 | EP1610820B1 High concentration antibody and protein formulations |
| 09/08/2010 | EP1562972B1 ALTERATION OF FcRn BINDING AFFINITIES OR SERUM HALF-LIVES OF ANTIBODIES BY MUTAGENESIS |
| 09/08/2010 | EP1478667B1 Anti-human tenascin monoclonal antibody |
| 09/08/2010 | EP1429797B1 Diagnosis and treatment of malignant neoplasms |
| 09/08/2010 | EP1412374B1 Novel pgc-1 isoforms and uses therefor |
| 09/08/2010 | EP1085905B1 Immunotherapeutic composition and method for the treatment of prostate cancer |
| 09/08/2010 | CN1942581B Antibody with osteoclast-related protein as target |
| 09/08/2010 | CN1750844B Use of lectin path specific CIq inhibitor for preparing pharmaceutical for preventing and treating tissue damage |
| 09/08/2010 | CN1711476B Non-competitive immunoassay for small analytes |
| 09/08/2010 | CN1566342B Antigenic epitope of S-protein of SARS coronavirus, antibody of S-protein of SARS coronavirus , nucleic acid encoding S-protein of SARS coronavirus and compositions containing same |
| 09/08/2010 | CN101828114A Method for sending mbms and choosing device |
| 09/08/2010 | CN101827936A CDH3 peptide and medicinal agent comprising the same |
| 09/08/2010 | CN101827863A Antibodies that bind IL-4 and/or IL-13 and their uses |
| 09/08/2010 | CN101827862A Humanized antibodies to Abeta(20-42) globulomer and uses thereof |
| 09/08/2010 | CN101827859A Insulin-like growth factor fusion proteins |
| 09/08/2010 | CN101827858A Leptin fusion proteins |
| 09/08/2010 | CN101827609A High affinity human antibodies to human nerve growth factor |
| 09/08/2010 | CN101824090A Monoclonal antibody hpam4 |
| 09/08/2010 | CN101824089A Anti-diabetic monoclonal antibody |
| 09/08/2010 | CN101824088A Inhibition of il-17 production |
| 09/08/2010 | CN101240021B Monoclonal antibody for anti-human CDK5RAP2 protein and application thereof |
| 09/07/2010 | US7790871 Anti-TNFα antibodies and methods of use |
| 09/07/2010 | US7790864 Antibody to BACE455, an alternative splice variant of the human beta-secretase |
| 09/07/2010 | US7790863 Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer |
| 09/07/2010 | US7790861 Nucleotide sequences coding polypeptide for use in the diagnosis of cancer in mammals |
| 09/07/2010 | US7790859 Interferon specific immunoglobulin for use in diagnosis, prevention and treatment of autoimmune diseases |
| 09/07/2010 | US7790858 Immunoadhesin comprising increased neonatal Fc receptor specificity for use in treatment and prevention of cell proliferative disorders |
| 09/07/2010 | US7790857 Brefeldin A (BFA4) specific immunoglobulin for use in diagnosis prevention and treatment of cell proliferative disorders |
| 09/07/2010 | US7790856 for treatment of diseases associated with amyloid deposits of A beta in the brain such as Alzheimer's disease |
| 09/07/2010 | US7790855 Used to diagnose and treat various diseases, including human cancers associated with expression and/or over-expression of KID3 |
| 09/07/2010 | US7790854 antibody zeta -C2 raised against the sequence set forth in SEQ ID NO:2, which specifically binds to the atypical isoform protein kinase M zeta (PKM zeta ); Alzheimer's disease (AD) and neuroblastoma; using aPKC in diagnosis, drug screening and gene therapy |
| 09/07/2010 | US7790853 Determination of bone-sialoprotein in bodily fluids for oncological problems |
| 09/07/2010 | US7790851 heterodimeric receptor complex comprising an isolated soluble cytokine receptor and a soluble zcytor11 polypeptide; for use in treatment of cell proliferative, inflammatory and immune disorders |
| 09/07/2010 | US7790848 g-protein coupled receptors for identifying modulators of taste enhancement; food processing and drug design; for screening tastants |
| 09/07/2010 | US7790843 Cypin polypeptide and fragments thereof |
| 09/07/2010 | US7790674 Treating inflammatory disease; use in combination with other antiinflammatory agents such as anakinra; rheumatoid arthritis for example; Ang-2 inhibitor peptides of amino acid sequence WDPWT |
| 09/07/2010 | US7790415 Increasing half-life of immunoglobulin fusion via alteration of carboxy-terminal with cytokine protein; directed protein evolution; antitumor agents |
| 09/07/2010 | US7790414 Methods for producing antibodies |
| 09/07/2010 | US7790408 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 09/07/2010 | US7790403 Methods for predicting preganancy outcome in a subject by hCG assay |
| 09/07/2010 | US7790399 Using epstein-barr virally transformed human B cell lines as bioreactors for Fc receptor specific immunoglobulins |
| 09/07/2010 | US7790376 PREFERENTIAL CLASSIFICATON BETWEEN CANCER CELLS; OBTAIN SAMPLE, MONITOR SAMPLE FOR PREFERENTIAL ENZYMATIC ACTIVITY, EVALUATE DIFFERENTIATED CELLS; for of detecting presence or absence or level of a polynucleotide sequence encoding heparanase in a biological sample |
| 09/07/2010 | US7790367 having determined antigen specificity, and having a variable fragment which is obtainable from a camelid heavy-chain immunoglobulin having two heavy polypeptide chains capable of recognizing and binding an antigen and which is further devoid of polypeptide light chains |
| 09/07/2010 | US7790366 NANBV diagnostics and vaccines |
| 09/07/2010 | US7790172 Methods for reducing nasopharyngeal colonization of non-typable Haemophilus influenzae with synthetic chimeric fimbrin peptides |
| 09/07/2010 | US7790167 Vaccine efficiency using immunology stimulants |
| 09/07/2010 | US7790166 Anti-CD40 antibodies capable of blocking B-cell activation |
| 09/07/2010 | US7790165 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases |
| 09/07/2010 | US7790164 Fab proteins; anticancer agents; immunoglobulins; gene expression inhibition; kits |
| 09/07/2010 | US7790162 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells |
| 09/07/2010 | US7790159 inhibiting viral replication or infection using a composition with a virally infected cell which has an immunoconjugate comprising a first anti-viral agent operatively attached to an antibody, or antigen-binding fragment, that binds to an aminophospholipid; treatment of cancer and viral infections |
| 09/07/2010 | US7790157 Methods of modulating CARK protein activity |
| 09/07/2010 | US7790152 Monoclonal antibodies that preferntially bind to proteins having cytolysis and immunogenic activity |
| 09/07/2010 | US7790144 Receptor-avid exogenous optical contrast and therapeutic agents |